NCT05814042View on ClinicalTrials.gov

Next Generation ORS: Controlled Trial Comparing ORS With Calcium vs Standard ORS in Reducing Severity of Acute Watery Diarrhea

PHASE2/PHASE3CompletedINTERVENTIONAL

Enrollment

396

Participants

Timeline

Start Date

August 21, 2023

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions

DiarrheaCholera

Interventions

DRUG

Next Generation ORS (oral rehydration solution) (including placebo

Nutrition used to stop diarrhea

DRUG

Current standard control ORS (oral rehydration solution)

current standard control ORS in diarrheic patients with cholera

Trial Locations (1)

1212

ICDDR,B Dhaka Hospital, Dhaka

All Listed Sponsors

collaborator

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

lead

University of Florida

OTHER

NCT05814042 - Next Generation ORS: Controlled Trial Comparing ORS With Calcium vs Standard ORS in Reducing Severity of Acute Watery Diarrhea | Biotech Hunter | Biotech Hunter